Clinical evaluation of CMA in the treatment of prostatic cancer
Forty five patients with previously untreated prostatic cancer were given chlormadinone acetate (CMA) at a dose of 100 mg/day (mean 12.6 months), and 42 of them were evaluated for effectiveness. Overall response evaluation revealed 19 complete responses (45.2%), 14 partial responses (33.3%), 4 minor...
| Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 32(1986), 12 vom: 30. Dez., Seite 1821-30 |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | , , , , , , |
| Format: | Aufsatz |
| Sprache: | Japanese |
| Veröffentlicht: |
1986
|
| Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica |
| Schlagworte: | English Abstract Journal Article Chlormadinone Acetate 0SY050L61N Testosterone 3XMK78S47O Luteinizing Hormone 9002-67-9 Follicle Stimulating Hormone 9002-68-0 mehr... |